Glaxosmithkline Pharmaceuticals shareholding pattern

GLAXO

HealthcareLarge

2794.1

24.50 (0.88%)
Last updated on 18 Aug, 2025 | 15:45 IST
BUYSELL

The current prices are delayed, login to your account for live prices

Glaxosmithkline Pharmaceuticals Shareholding Pattern

  • 2016-17
  • 2018-19
  • 2019-20
  • 2020-21
  • 2021-22
  • 2022-23
  • 2025-26
  • 2024-25
  • 2023-24
Total Promoters
Segment
Percent

Total Promoters

75%

Mutual Fund

4.96%

Insurance

2.23%

Foreign Institutional Investors

4.5%

Domestic Institutional Investors

0.11%

Retail

13.19%

Others

0.01%

Total Promoters
MAR '24
75%
JUN '24
75%
SEP '24
75%
DEC '24
75%

Glaxosmithkline Pharmaceuticals FAQs

As of 08-2025, the promoter shareholding in Glaxosmithkline Pharmaceuticals stands at 75% of the company's total shares. Promoter shareholding represents the ownership stake held by the company's founding members, management, or controlling entities, having a significant influence on the company's strategic direction and operations.

The FII and DII shareholding of Glaxosmithkline Pharmaceuticals is 4.89% and 0.14% respectively.

The retail shareholding of the Glaxosmithkline Pharmaceuticals is 12.41%.

Changes in shareholding patterns of Glaxosmithkline Pharmaceuticals can result from stock market transactions, issuance of new shares, buybacks, mergers, acquisitions, or changes in promoter holdings.

Shareholding patterns of Glaxosmithkline Pharmaceuticals are updated quarterly as mandated by regulatory authorities and may also be disclosed during significant corporate events.

The latest shareholding pattern is available on stock exchanges (e.g., NSE, BSE) and the company's official website under investor relations.